Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dwight Owens

Psychiatry Atlanta, GA Medical Doctor

NPI 1518989433 CMS profile 114628

1720 Peachtree St Nw, Ste 640, Suite 640, Atlanta, GA 31131

Open in the dashboard

General payments

$23,880

69 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dwight Owens of Atlanta, GA is reported in the CMS Open Payments database as having received $23,880 across 69 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $389 10
2024 General $1,690 6
2023 General $48 2
2022 General $1,369 2
2021 General $1,328 2
2020 General $8,091 18
2019 General $10,965 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dwight Owens
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Dwight Owens were reported at $389. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Dwight Owens Psychiatry median Middle half National median
2019 $10,965 $184 $59–$605 $163
2020 $8,091 $119 $36–$372 $114
2021 $1,328 $143 $43–$576 $132
2022 $1,369 $153 $50–$590 $149
2023 $48 $170 $56–$651 $160
2024 $1,690 $179 $57–$673 $164
2025 $389 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $18,792 32 payments
  2. AbbVie, Inc. $2,678 3 payments
  3. Neuronetics, Inc. $1,633 3 payments
  4. Tris Pharma Inc $218 11 payments
  5. Teva Pharmaceuticals USA, Inc. $125 1 payment
  6. Otsuka America Pharmaceutical, Inc. $113 6 payments
  7. Novo Nordisk Inc $100 1 payment
  8. Janssen Pharmaceuticals, Inc $56 3 payments
  9. Takeda Pharmaceuticals U.S.A., Inc. $46 3 payments
  10. Avanir Pharmaceuticals, Inc. $43 2 payments
  11. Other $75 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $21,150 13 payments
  2. Food and Beverage $1,696 48 payments
  3. Travel and Lodging $1,034 8 payments
Products named General payments · program years 2019–2025
  1. VRAYLAR Neuroscience $18,792 32 payments
  2. VRAYLAR Neuroscience $2,678 3 payments
  3. Neurostar TMS Therapy System $1,621 2 payments
  4. Dyanavel XR $172 9 payments
  5. UZEDY $125 1 payment
  6. REXULTI $113 6 payments
  7. Ozempic $100 1 payment
  8. SPRAVATO $56 3 payments
  9. Onyda XR $45 2 payments
  10. NUEDEXTA $43 2 payments
  11. Other $176 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

193

Median for Psychiatry: 574

Drug cost

$6,862

Median for Psychiatry: $27,624

Branded share of claims

6.7%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Aripiprazole Generic 26 $5,735
Bupropion Xl Bupropion Hcl Brand 13 $324
Escitalopram Oxalate Generic 35 $239
Quetiapine Fumarate Generic 12 $210
Mirtazapine Generic 20 $125
Haloperidol Generic 11 $119
Clonazepam Generic 51 $61
Buspirone Hcl Generic 13 $40
Alprazolam Generic 12 $9

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$17,265

Medicare's payments for the services billed

Medicare patients

107

Average age 61

Services billed

179

47 women, 60 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 61%
Diabetes 50%
Arthritis 36%
Ischemic heart disease 35%
Chronic kidney disease 33%
Alzheimer's or dementia 32%
COPD 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Dyanavel XR
  • Tris Pharma Inc $69
$69 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record